Adairs Limited logo

Adairs Limited (1FQ)

Market Closed
20 Feb, 20:00
XFRA XFRA
1. 05
+0.03
+2.94%
- Market Cap
- P/E Ratio
- Div Yield
186 Volume
- Eps
1.02
Previous Close
Day Range
1.05 1.05
Year Range
0.92 1.8
Want to track 1FQ and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!

Summary

1FQ closed Friday higher at €1.05, an increase of 2.94% from Thursday's close, completing a monthly increase of 6.06% or €0.06. Over the past 12 months, 1FQ stock gained 6.06%.
1FQ pays dividends to its shareholders, with the most recent payment made on Oct 07, 2025. The next announced payment will be in In 1 month on Apr 07, 2026 for a total of €0.055.
The last earnings report, released on Yesterday at 12:00 AM, exceeded the consensus estimates by 0%. On average, the company has surpassed earnings expectations by 0.01%, based on the last three reports.
The stock of the company had never split.
The company's stock is traded on 3 different exchanges and in various currencies, with the primary listing on ASX (AUD).

1FQ Chart

Adairs Limited (1FQ) FAQ

What is the stock price today?

The current price is €1.05.

On which exchange is it traded?

Adairs Limited is listed on ASX.

What is its stock symbol?

The ticker symbol is 1FQ.

Does it pay dividends? What is the current yield?

It does not pay dividends to its shareholders.

What is its market cap?

As of today, no market cap data is available.

Has Adairs Limited ever had a stock split?

No, there has never been a stock split.

Adairs Limited Profile

Specialty Retail Industry
Consumer Discretionary Sector
Mr. Jatinder Dhaliwal CEO
XFRA Exchange
AU000000ADH2 ISIN
Canada Country
- Employees
10 Mar 2026 Last Dividend
- Last Split
- IPO Date

Overview

Global Health Clinics Ltd. is a company entrenched in the burgeoning cannabis industry, focusing on the medicinal aspects of marijuana and psilocybin. Initially established as Leo Resources Inc., the company underwent a significant rebranding to Global Health Clinics Ltd. in August 2018, signaling a shift towards a health-centered operation. Founded in 2013 and headquartered in Vancouver, Canada, this enterprise has carved out a niche by operating medical clinics. These clinics play a crucial role in navigating patients through the legal frameworks required to become authorized marijuana users for medicinal purposes. The shift from its original name to Global Health Clinics Ltd. underscores the company's commitment to advancing global health through innovative and legally sanctioned means.

Products and Services

  • Medical Clinics for Cannabis
  • Global Health Clinics Ltd. specializes in operating medical clinics dedicated to assisting patients in becoming legal users of cannabis for therapeutic purposes. These clinics serve as a critical bridge between traditional healthcare and alternative medicine, providing patients with legal, safe, and medically supervised access to cannabis under current regulations.

  • Psilocybin Product Development
  • The company is also at the forefront of developing psilocybin products, primarily for research purposes and potential pharmaceutical application. This involvement showcases its commitment to exploring and pioneering the medical benefits of psilocybin, a substance found in psychedelic mushrooms, which recent research suggests might offer significant therapeutic benefits for various mental health conditions.

Contact Information

Address: 837 West Hasting Street
Phone: (604) 283-1722